<VariationArchive VariationID="2891124" VariationName="NM_001414.4(EIF2B1):c.773_777dup (p.Ala260fs)" VariationType="Duplication" Accession="VCV002891124" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3045225" VariationID="2891124">
      <GeneList>
        <Gene Symbol="EIF2B1" FullName="eukaryotic translation initiation factor 2B subunit alpha" GeneID="1967" HGNC_ID="HGNC:3257" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="123620406" stop="123633686" display_start="123620406" display_stop="123633686" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="124105569" stop="124118322" display_start="124105569" display_stop="124118322" Strand="-" />
          </Location>
          <OMIM>606686</OMIM>
        </Gene>
        <Gene Symbol="LOC126861664" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr12:124105924-124107123" GeneID="126861664" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="123621377" stop="123622576" display_start="123621377" display_stop="123622576" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001414.4(EIF2B1):c.773_777dup (p.Ala260fs)</Name>
      <CanonicalSPDI>NC_000012.12:123621896:GACCT:GACCTGACCT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="123621896" stop="123621897" display_start="123621896" display_stop="123621897" variantLength="5" positionVCF="123621896" referenceAlleleVCF="C" alternateAlleleVCF="CGACCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="124106443" stop="124106444" display_start="124106443" display_stop="124106444" variantLength="5" positionVCF="124106443" referenceAlleleVCF="C" alternateAlleleVCF="CGACCT" />
      </Location>
      <ProteinChange>A260fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.123621897_123621901dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.123621897_123621901dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015862.1" sequenceAccession="NG_015862" sequenceVersion="1" change="g.16876_16880dup">
            <Expression>NG_015862.1:g.16876_16880dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015862.2" sequenceAccession="NG_015862" sequenceVersion="2" change="g.16785_16789dup">
            <Expression>NG_015862.2:g.16785_16789dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_086162.1" sequenceAccession="NG_086162" sequenceVersion="1" change="g.621_625dup">
            <Expression>NG_086162.1:g.621_625dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001414.4" sequenceAccession="NM_001414" sequenceVersion="4" change="c.773_777dup" MANESelect="true">
            <Expression>NM_001414.4:c.773_777dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001405.1" sequenceAccession="NP_001405" sequenceVersion="1" change="p.Ala260fs">
            <Expression>NP_001405.1:p.Ala260fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.124106444_124106448dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.124106444_124106448dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001414.4(EIF2B1):c.773_777dup (p.Ala260fs) AND not provided" Accession="RCV003722817" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18263758</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26285592</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32865661</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33334879</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34663487</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8305567" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="7818028|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004518127" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18263758</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26285592</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32865661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33334879</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34663487</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala260Argfs*23) in the EIF2B1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 46 amino acid(s) of the EIF2B1 protein. This variant is present in population databases (rs779473190, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with EIF2B1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the EIF2B1 protein in which other variant(s) (p.Tyr275Cys) have been determined to be pathogenic (PMID: 18263758, 26285592, 32865661, 33334879, 34663487). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EIF2B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.124106443_124106444insGACCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8305567" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

